Relationship between autistic traits and social functioning in healthy individuals.

adaptive behavior autism spectrum disorder childhood & adolescent disorders interpersonal skill social skill

Journal

Neuropsychopharmacology reports
ISSN: 2574-173X
Titre abrégé: Neuropsychopharmacol Rep
Pays: United States
ID NLM: 101719700

Informations de publication

Date de publication:
06 2022
Historique:
revised: 08 03 2022
received: 14 01 2022
accepted: 09 03 2022
pubmed: 3 4 2022
medline: 25 6 2022
entrez: 2 4 2022
Statut: ppublish

Résumé

Social functioning is influenced by various factors. Autistic traits could be one of the factors that affect social functioning. In the present study, the relationship between autistic traits and social functioning among 755 healthy individuals was analyzed. Autistic traits were assessed with the autism-spectrum quotient. Social functioning was assessed by the social functioning scale and the social activity assessment. The Autism-Spectrum Quotient total score was significantly negatively correlated with the social functioning scale total and all subscales of the social functioning scale. All subscales of the Autism-Spectrum Quotient except attention to detail were significantly negatively correlated with the social functioning scale total score. However, the Autism-Spectrum Quotient was not correlated with the social activity assessment, which indicates labor functioning. Autistic traits of healthy individuals had a negative impact on situations in real life through social functioning for daily life-sustaining. The effect was not enough to affect labor functioning as indicated by working hours in healthy individuals. These findings should also be examined in individuals with autism spectrum disorder in future studies.

Identifiants

pubmed: 35365959
doi: 10.1002/npr2.12249
pmc: PMC9216356
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

226-229

Informations de copyright

© 2022 The Authors. Neuropsychopharmacology Reports published by John Wiley & Sons Australia, Ltd on behalf of The Japanese Society of Neuropsychopharmacology.

Références

Psychiatry Clin Neurosci. 2020 Dec;74(12):652-658
pubmed: 32940406
Psychiatry Clin Neurosci. 2020 Mar;74(3):191-203
pubmed: 31793131
Br J Psychiatry. 1990 Dec;157:853-9
pubmed: 2289094
J Am Acad Child Adolesc Psychiatry. 2013 Jun;52(6):572-81.e1
pubmed: 23702446
Neuropsychopharmacol Rep. 2022 Jun;42(2):226-229
pubmed: 35365959
Schizophr Res. 2018 Nov;201:172-179
pubmed: 30473032
Shinrigaku Kenkyu. 2004 Apr;75(1):78-84
pubmed: 15724518
J Autism Dev Disord. 2001 Feb;31(1):5-17
pubmed: 11439754

Auteurs

Yuria Demizu (Y)

Department of Developmental and Clinical Psychology, The Division of Human Developmental Sciences, Graduate School of Humanity and Sciences, Ochanomizu University, Tokyo, Japan.
Department of Pathology of Mental Diseases, National Center of Neurology and Psychiatry, National Institute of Mental Health, Tokyo, Japan.

Junya Matsumoto (J)

Department of Pathology of Mental Diseases, National Center of Neurology and Psychiatry, National Institute of Mental Health, Tokyo, Japan.

Yuka Yasuda (Y)

Department of Pathology of Mental Diseases, National Center of Neurology and Psychiatry, National Institute of Mental Health, Tokyo, Japan.
Life Grow Brilliant Mental Clinic, Medical Corporation Foster, Osaka, Japan.

Satsuki Ito (S)

Department of Developmental and Clinical Psychology, The Division of Human Developmental Sciences, Graduate School of Humanity and Sciences, Ochanomizu University, Tokyo, Japan.
Department of Pathology of Mental Diseases, National Center of Neurology and Psychiatry, National Institute of Mental Health, Tokyo, Japan.

Kenichiro Miura (K)

Department of Pathology of Mental Diseases, National Center of Neurology and Psychiatry, National Institute of Mental Health, Tokyo, Japan.

Hidenaga Yamamori (H)

Department of Pathology of Mental Diseases, National Center of Neurology and Psychiatry, National Institute of Mental Health, Tokyo, Japan.
Department of Psychiatry, Graduate School of Medicine, Osaka University, Osaka, Japan.
Japan Community Health Care Organization Osaka Hospital, Osaka, Japan.

Michiko Fujimoto (M)

Department of Pathology of Mental Diseases, National Center of Neurology and Psychiatry, National Institute of Mental Health, Tokyo, Japan.
Department of Psychiatry, Graduate School of Medicine, Osaka University, Osaka, Japan.

Naomi Hasegawa (N)

Department of Pathology of Mental Diseases, National Center of Neurology and Psychiatry, National Institute of Mental Health, Tokyo, Japan.

Keiichiro Ishimaru (K)

Department of Pathology of Mental Diseases, National Center of Neurology and Psychiatry, National Institute of Mental Health, Tokyo, Japan.
Faculty of Core Research, Ochanomizu University, Tokyo, Japan.

Ryota Hashimoto (R)

Department of Pathology of Mental Diseases, National Center of Neurology and Psychiatry, National Institute of Mental Health, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH